BIGG

Início > Guias GRADE > Resultado da busca

Resultados: 2

Systemic therapy for melanoma: ASCO guideline update

Seth, Rahul; Agarwala, Sanjiv S; Messersmith, Hans; Alluri, Krishna C; Ascierto, Paolo A; Atkins, Michael B; Bollin, Kathryn; Chacon, Matias; Davis, Nancy; Faries, Mark B; Funchain, Pauline; Gold, Jason S; Guild, Samantha; Gyorki, David E; Kaur, Varinder; Khushalani, Nikhil I; Kirkwood, John M; McQuade, Jennifer Leigh; Meyers, Michael O; Provenzano, Anthony; Robert, Caroline; Santinami, Mario; Sehdev, Amikar; Sondak, Vernon K; Spurrier, Gilliosa; Swami, Umang; Truong, Thach-Giao; Tsai, Katy K; van Akkooi, Alexander; Weber, Jeffrey.
J. clin. oncol; 41 (30), 2023
To provide guidance to clinicians regarding the use of systemic therapy for melanoma. American Society of Clinical Oncology convened an Expert Panel and conducted an updated systematic review of the literature. The updated review identified 21 additional randomized trials. Neoadjuvant pembrolizumab was n...
Melanoma/imunologia, Nivolumabe/uso terapêutico, Antineoplásicos Imunológicos, Mutação/imunologia
Texto completo

Nivolumab with platinum- and fluoropyrimidine-based chemotherapy for untreated HER2-negative advanced gastric, gastro-oesophageal junction or oesophageal adenocarcinoma

England. National Institute for Health and Care Excellence.
Next Evidence-based recommendations on nivolumab (Opdivo) with platinum- and fluoropyrimidine-based chemotherapy for untreated HER2-negative advanced gastric, gastro-oesophageal junction or oesophageal adenocarcinoma in adults. Commercial arrangement There is a commercial access agreement for nivolumab...
Nivolumabe/uso terapêutico, Antimetabólitos/uso terapêutico, Inibidores de Checkpoint Imunológico/uso terapêutico, Neoplasias Esofágicas/terapia, Metástase Neoplásica/prevenção & controle
Texto completo (link principal)     Texto completo (link alternativo)